EyePoint Pharmaceuticals, Inc. (EYPT) vs Century Therapeutics, Inc. (IPSC)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and Century Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.08HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
IPSC
Century Therapeutics, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — EYPT vs IPSC
growth of $100 · dividends reinvested · last 5yEYPT -67.6% (-20.2%/yr)IPSC -93.5% (-42.1%/yr)EYPT compounded faster over this window
EYPT IPSC
EYPT vs IPSC: by the numbers
- •EYPT is the larger company ($258M vs $255M market cap).
- •Both run net losses; IPSC's is the smaller (-8.78% vs -10994.73% net margin).
Metrics side by side
Valuation
| Metric | EYPT | IPSC |
|---|---|---|
| P/S ratio | 92.68 | N/A |
| P/B ratio | 1.55 | 1.10 |
Profitability
| Metric | EYPT | IPSC |
|---|---|---|
| Gross margin | 93.41% | 88.00% |
| Operating margin | -775.98% | -13.78% |
| Net margin | -10994.73% | -8.78% |
| ROE | -184.27% | -47.25% |
| ROIC | -170.19% | -43.69% |
Growth (annualized)
| Metric | EYPT | IPSC |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | N/A |
| Total return CAGR (5Y) | -21.68% | -42.05% |
Frequently asked
- How have EYPT and IPSC total returns compared?
- Over the past 5 years, EYPT delivered -21.68% and IPSC delivered -42.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.